Results
1 -
10 of
169
(Click
here to explore results)
- Drug Discovery for Psychiatric Disorders, CHAPTER 8 Beyond SSRIs: Second-generation Reuptake Inhibitors for the Treatment of Depression. Peter T. Gallagher
, 2012
, Pages 184-225
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 13 5‐HT1A Receptors as a Therapeutic Target for Parkinson’s Disease. Saki Shimizu, Yukihiro Ohno
, 2013
, Pages 308-326
- Emerging Drugs and Targets for Alzheimer's Disease: Volume 2: Neuronal Plasticity, Chapter 23 Serotonin 5-HT4 Receptors as Pharmacological Targets for the Treatment of Alzheimer's Disease. Isabelle Berque-Bestel, Frank Lezoualc'h
, 2010
, Volume 2
, Pages 169-190
- Drug Discovery for Psychiatric Disorders, CHAPTER 3 Monoaminergic Approaches for Treatment of Schizophrenia. David P. Rotella
, 2012
, Pages 35-55
- Drug Discovery for Psychiatric Disorders, CHAPTER 7 The Neurobiology of Depression and Anxiety: How Do We Change from Models of Drug Efficacy to Understanding Mood and Anxiety Disorders?. Georgia E. Hodes, Scott J. Russo
, 2012
, Pages 159-183
- Allosterism in Drug Discovery, CHAPTER 16 Allosteric Binding in the Serotonin Transporter – Pharmacology, Structure, Function and Potential Use as a Novel Drug Target. Claus J. Loland, Connie Sanchez, Per Plenge, Klaus P. Bøgesø, Benny Bang-Andersen
, 2017
, Pages 360-380
- Drug Discovery for Psychiatric Disorders, CHAPTER 19 Multi-target Drug Discovery for Psychiatric Disorders. Zoran Rankovic, Richard Morphy
, 2012
, Pages 510-533
- Drug Discovery for Psychiatric Disorders, CHAPTER 21 Translational PET Imaging Research in Psychiatry. Richard J. Hargreaves, Eugenii A. Rabiner
, 2012
, Pages 558-573
- Drug Discovery for Psychiatric Disorders, CHAPTER 6 Treating the Cognitive Deficits of Schizophrenia. Bruce N. Rogers, David L. Gray
, 2012
, Pages 123-156
- Pain Therapeutics: Current and Future Treatment Paradigms, CHAPTER 5 Neurotransmitters and Other Non-Opiate Central Mechanisms. Simon E. Ward
, 2014
, Pages 171-196